Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients
Clinical trial NCT01588145 · COMPLETED
Trial details
- NCT number
- NCT01588145
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2017-08-01
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.